IMPROVING THERAPY FOR SKIN DISEASES
Live / Registered — Registered (as of 18 Jan 2022)
What this means for you
Registered since 18 Jan 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90452253
- Registration number
- 6618593
- Mark type
- Stylized text
- Filed
- 07 Jan 2021
- Published for opposition
- 02 Nov 2021
- Registered
- 18 Jan 2022
- Attorney of record
- Michael J. Hertz
Goods and services
- Class 042 — Scientific and technological services: Research and development of drugs and medicines for the treatment of infections, lung diseases, and skin diseases; Research and development in the pharmaceutical, life sciences, and biomedicine fields; Scientific research, testing, and analysis in the fields of pharmaceuticals, life science, and biomedicine; Medical and scientific research on lung diseases, skin diseases, infections, and cancer; Pharmaceutical products testing, analysis, research, and development
Owner
- ALPHYN BIOLOGICS, INC., ANNAPOLIS, MD, US
- Alphyn Biologics, LLC, Annapolis, MD, US
- Alphyn Biologics, LLC, Annapolis, MD, US
- Alphyn Biologics, LLC, Annapolis, MD, US
Prosecution history
- 01 Nov 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 18 Jul 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Jul 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 18 Jul 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 18 Jan 2022 — REGISTERED-PRINCIPAL REGISTER
- 02 Nov 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Nov 2021 — PUBLISHED FOR OPPOSITION
- 13 Oct 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Sept 2021 — NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
- 28 Sept 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 Sept 2021 — USE AMENDMENT ACCEPTED
- 16 Sept 2021 — AMENDMENT TO USE PROCESSING COMPLETE
- 16 Sept 2021 — USE AMENDMENT FILED
- 15 Sept 2021 — TEAS AMENDMENT OF USE RECEIVED
- 12 Jul 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED